A Phase II Study of Maintenance With Azacitidine in MDS Patients
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
A phase II multicentre trial of maintenance with Azacitidine in MDS patients achieving
complete or partial remission (CR or PR) after intensive chemoterapy.
The primary objective is response duration (MDS or AML)